Millions of people with Medicare and Medicaid could benefit from expanded coverage of GLP-1s for obesity Overall, CMSs efforts to expand Medicare and Medicaid coverage of GLP-1s for people with Medicare and Medicaid could greatly expand access to these drugs, albeit on a temporary basis, depending on the level of participation by drug manufacturers, state Medicaid agencies and Part D plans
Bariatric surgery, which includes procedures like sleeve gastrectomy and gastric bypass, has long been considered an effective solution for severe obesity
Back Pesheva, K (18 June 2018) 'Gut Hormone Insights', Harvard Medical School News & Research
This causes problems with movement, mental and behavioral changes, and often premature death
The difference lies in tirzepatides ability to mimic the gastric-inhibitory polypeptide (GIP) hormone as well as the GLP-1 hormone